Global market for biomarkers is likely to touch $34 billion by 2017
Shalini Gupta finds out more in an interview with Sanjeev Johar, Chief Executive Officer, Alere India
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Archive
CDSCO approval to market Ranbaxys Synriam in India for treatment of malaria
The phase III clinical trials for the drug conducted in India successfully demonstrated the efficacy and tolerability of Synriam…
Novozymes Biopharma in collaboration with Almac
To provide a combined service for drug development applications in the field of drug targeting and pharmacokinetic improvements
Janssen submits marketing authorisation application to European Medicines Agency
Seeks approval for its fixed-dose combination tablet of HIV-1 medicine
Pharma market sees growth of 1.8 per cent in September 2013
Anti diabetics, cardiac and derma therapies have shown strong growth
Arvind Remedies signs MoU with four institutions
Together they have developed patented medicines which are useful for the treatment and management of neuro-degeneration disorder
IPM posts first ever negative growth in Sept
Valued at Rs 6331 crores in September 2013; it has grown at -1.80 per cent
DigiSights India 2013 to be held in Mumbai
Conference in Mumbai on November 15, 2013 will project thoughts from Indian marketers, including some case-studies
Innovation to drive the agenda at 11th edition of BioAsia
Event to be held at HICC from February 17 to 19, 2014
FEAPM, CIPI join PHARMA Pro&Pack Expo 2014
Special pavilion for analytical instruments products and services
Pharmatech Expo 2013 showcases latest pharma, lab and packaging equipment
PharmaTechnologyIndex.com with IDMA, Pharmexcil and Ministry of MSME organise ‘central India’s largest pharma expo’
Strategies for tough times
Squeezed between stringent regulations on the home front and sluggish global economic conditions, the Indian pharmaceutical market…
Multisorb Technologies to exhibit solutions for pharmaceutical stability at MEDICA/COMPAMED 2013
To have experienced staff on hand to discuss its solutions for stabilising pharmaceutical, in-vitro diagnostic, medical device,…
Indoco’s sales and EBIDTA margins improve substantially
Posts total revenue growth of 24.8 per cent at Rs 2023 million
Lupin posts robust profits, sees consistent growth
Net sales up 18 per cent; EBITDA up 42 per cent and net profit up 40 per cent
Venus Remedies to launch Elores in Latin America next year
Expects to generate a revenue of $5 million within three years of the launch
Merck India provides solution to overcome counterfeiting
Helps in reducing health hazards and also increasing safety of consumers
Alembic Pharmaceuticals revenues up 20 per cent at Rs 488 crores for quarter ended September 30th,…
PBT up 52 per cent at Rs 80.49 crores